Second Circuit declines to hear appeal in Aggrenox reverse-payment case
MLex Summary: The US Court of Appeals for the Second Circuit has denied an interlocutory appeal by Barr Pharmaceuticals and other defendants accused of illegally delaying generic entry of the drug...To view the full article, register now.
Already a subscriber? Click here to view full article